LIPOPROTEIN (A) - IMPLICATION IN ATHEROTHROMBOSIS

被引:30
作者
CHAPMAN, MJ
HUBY, T
NIGON, F
THILLET, J
机构
[1] INSERM Unité 321, Unité de Recherche sur les Lipoprotéines et l'Athérogénèse, Hôpital de la Pitié, 75651 Paris Cedex 13, Pavillon Benjamin Delessert
关键词
APOLIPOPROTEIN(A); APO(A) ISOFORM; FIBRIN; PLASMINOGEN; CORONARY ARTERY DISEASE;
D O I
10.1016/0021-9150(94)05385-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substantial experimental evidence now implicates lipoprotein (a) as an independent risk factor for premature cardiovascular disease. Both plasma Lp(a) levels and apo(a) phenotype are strong predictors of risk for ischaemic heart disease. The accumulation of apo(a) in vascular wall tissue and in atherosclerotic plaques and the potential inhibition of fibrinolysis by Lp(a) underlie the enhanced risk of premature cardiovascular disease associated with this cholesterol-rich particle. Recent studies of the capacity of purified Lp(a) isoforms to inhibit fibrinolysis in an in vitro system have revealed that small isoforms of Lp(a) (less than or equal to 500 kDa) are efficient inhibitors of plasminogen activation and bind with high affinity to fibrin. Conversely, large isoforms exert little or no inhibitory effect in this system (> 500 kDa). These data suggest that the potential, high affinity interaction of Lp(a) particles containing small isoforms with fibrin introduces a new, third dimension to the atherothrombotic risk associated with these cholesterol rich particles.
引用
收藏
页码:S69 / S75
页数:7
相关论文
共 38 条
  • [1] BEISIEGEL U, 1991, CURR OPIN LIPIDOL, V2, P317
  • [2] FAT FEEDING IN HUMANS INDUCES LIPOPROTEINS OF DENSITY LESS THAN 1.006 THAT ARE ENRICHED IN APOLIPOPROTEIN [A] AND THAT CAUSE LIPID-ACCUMULATION IN MACROPHAGES
    BERSOT, TP
    INNERARITY, TL
    PITAS, RE
    RALL, SC
    WEISGRABER, KH
    MAHLEY, RW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) : 622 - 630
  • [3] SERUM-LP(A) AS A DISCRIMINANT MARKER OF EARLY ATHEROSCLEROTIC PLAQUE AT 3 EXTRACORONARY SITES IN HYPERCHOLESTEROLEMIC MEN
    CAMBILLAU, M
    SIMON, A
    AMAR, J
    GIRAL, P
    ATGER, V
    SEGOND, P
    LEVENSON, J
    MERLI, I
    MEGNIEN, JL
    PLAINFOSSE, MC
    MOATTI, N
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (11): : 1346 - 1352
  • [4] APOLIPOPROTEIN-(A) - A COMPARISON OF ISOFORMS IDENTIFIED BY SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL-ELECTROPHORESIS OR BY SODIUM DODECYL SULFATE-AGAROSE GEL-ELECTROPHORESIS
    CRAIG, WY
    POULIN, SE
    LEDUE, TB
    KAMBOH, MI
    [J]. ELECTROPHORESIS, 1993, 14 (10) : 1038 - 1041
  • [5] PARTIAL AMINO-ACID-SEQUENCE OF APOLIPOPROTEIN(A) SHOWS THAT IT IS HOMOLOGOUS TO PLASMINOGEN
    EATON, DL
    FLESS, GM
    KOHR, WJ
    MCLEAN, JW
    XU, QT
    MILLER, CG
    LAWN, RM
    SCANU, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) : 3224 - 3228
  • [6] PROTEIN AND CARBOHYDRATE COMPOSITION OF LP (A) LIPOPROTEIN FROM HUMAN PLASMA
    EHNHOLM, C
    RENKONEN, O
    SIMONS, K
    GAROFF, H
    [J]. BIOCHEMISTRY, 1972, 11 (17) : 3229 - +
  • [7] FLESS GM, 1984, J BIOL CHEM, V259, P1470
  • [8] FLESS GM, 1990, J LIPID RES, V31, P909
  • [9] GAUBATZ JW, 1990, J LIPID RES, V31, P603
  • [10] GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582